Early trial tests new shot to boost Body's fight against HIV
NCT ID NCT06680479
Summary
This early-stage study is testing a new therapeutic vaccine in adults who are living with HIV and have their virus well-controlled with daily medication. The main goals are to check if the vaccine is safe and to see if it can teach the body's immune system to better fight the virus. About 30 participants will be monitored for up to 100 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Case CRS
Cleveland, Ohio, 44106, United States
-
Chapel Hill CRS
Chapel Hill, North Carolina, 27599-7215, United States
-
Cincinnati CRS
Cincinnati, Ohio, 45267-0405, United States
-
Columbia Physicians & Surgeons (P&S) CRS
New York, New York, 10032, United States
-
Harbor University of California Los Angeles Center CRS
Torrance, California, 90502-2052, United States
-
Houston Advancing Research Team CRS
Houston, Texas, 77030, United States
-
Johns Hopkins University CRS
Baltimore, Maryland, 21287, United States
-
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, 02114, United States
-
New Jersey Medical School Clinical Research Center CRS
Newark, New Jersey, 07103, United States
-
Northwestern University CRS
Chicago, Illinois, 60611, United States
-
Ohio State University CRS
Columbus, Ohio, 43210, United States
-
Penn Therapeutics CRS
Philadelphia, Pennsylvania, 19104, United States
-
The Ponce de Leon Center CRS
Atlanta, Georgia, 30308-2012, United States
-
UCSD Antiviral Research Center CRS
San Diego, California, 92103, United States
-
University of California, Los Angeles CARE Center CRS
Los Angeles, California, 90035, United States
-
University of California, San Francisco HIV/AIDS CRS
San Francisco, California, 94110, United States
-
University of Colorado Hospital CRS
Aurora, Colorado, 80045, United States
-
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, 15213, United States
-
University of Rochester Adult HIV Therapeutic Strategies Network CRS
Rochester, New York, 14642, United States
-
University of Washington Positive Research CRS
Seattle, Washington, 98104, United States
-
Vanderbilt Therapeutics (VT) CRS
Nashville, Tennessee, 37204, United States
-
Washington University Therapeutics (WT) CRS
St Louis, Missouri, 63110-1010, United States
-
Weill Cornell Chelsea CRS
New York, New York, 10010, United States
-
Weill Cornell Uptown CRS
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.